Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caineng Cao

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Geriatric Oncology|May 16, 2025
Concurrent chemotherapy for older patients with locoregionally advanced nasopharyngeal carcinoma: A randomized clinical trialCaineng Cao, Yuting Fang, Feng Jiang, et al.
La Radiologia Medica|February 4, 2015
Definitive intensity-modulated radiotherapy compared with definitive conventional radiotherapy in cervical oesophageal squamous cell carcinomaCaineng Cao, Jingwei Luo, Li Gao, et al.
Neoplasia (New York, N.Y.)|March 16, 2025
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastomaCaineng Cao, Le Wang, Feng Jiang, et al.
The Lancet. Oncology|February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort studyCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2025
Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaYuting Fang, Binhao Wu, Rong Zhang, et al.
Head & Neck|October 21, 2025
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of FailureCaineng Cao, Teeradon Treechairusame, Nadeem Riaz, et al.
Frontiers in Oncology|August 28, 2020
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical TrialXiaodong Huang, Xiaozhong Chen, Chong Zhao, et al.
Lancet Regional Health. Americas|January 19, 2026
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control studyCaineng Cao, Teeradon Treechairusame, Amir H Safavi, et al.
JAMA Network Open|October 24, 2025
Updated Estimates of Patients With Oropharyngeal Cancer in the USCaineng Cao, Anna Lee, Jung Julie Kang, et al.
Frontiers in Oncology|November 26, 2020
Nutritional Status and Its Association With Radiation-Induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma During Radiotherapy: A Prospective StudyZekai Shu, Ziyi Zeng, Bingqi Yu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Geriatric Oncology|May 16, 2025
Concurrent chemotherapy for older patients with locoregionally advanced nasopharyngeal carcinoma: A randomized clinical trialCaineng Cao, Yuting Fang, Feng Jiang, et al.
La Radiologia Medica|February 4, 2015
Definitive intensity-modulated radiotherapy compared with definitive conventional radiotherapy in cervical oesophageal squamous cell carcinomaCaineng Cao, Jingwei Luo, Li Gao, et al.
Neoplasia (New York, N.Y.)|March 16, 2025
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastomaCaineng Cao, Le Wang, Feng Jiang, et al.
The Lancet. Oncology|February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort studyCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2025
Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaYuting Fang, Binhao Wu, Rong Zhang, et al.
Head & Neck|October 21, 2025
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of FailureCaineng Cao, Teeradon Treechairusame, Nadeem Riaz, et al.
Frontiers in Oncology|August 28, 2020
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical TrialXiaodong Huang, Xiaozhong Chen, Chong Zhao, et al.
Lancet Regional Health. Americas|January 19, 2026
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control studyCaineng Cao, Teeradon Treechairusame, Amir H Safavi, et al.
JAMA Network Open|October 24, 2025
Updated Estimates of Patients With Oropharyngeal Cancer in the USCaineng Cao, Anna Lee, Jung Julie Kang, et al.
Frontiers in Oncology|November 26, 2020
Nutritional Status and Its Association With Radiation-Induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma During Radiotherapy: A Prospective StudyZekai Shu, Ziyi Zeng, Bingqi Yu, et al.
Pageof 5